New research and technology are bringing innovative medicines to market. IngenioRx’s experts are tracking the development and approval of new treatments to keep you informed. The Q2 updates of our quarterly reports focus on recent and pending FDA approvals. DrugInsights lists recent approvals. The Drug and Biologic Pipeline Update analyzes drugs and therapeutics in development and looks at emerging new therapies and significant product approvals. It also offers analysis of market trends and includes an update on multiple sclerosis (MS) and the future of MS treatments. Visit Ingenio-Rx.com regularly for the latest information about new and emerging drugs and therapeutics.